RSV Vaccine: 4 Questions Answered
The world’s first RSV vaccine could be rolled out by fall 2023, in time for the typical winter surge in RSV infections.
Diagnosis & Disease Information
RSV Vaccine Arexvy Wins FDA Approval for Older Adults
Arexvy is expected to be available for the 2023-2024 RSV season.
Pfizer-BioNTech Bivalent Booster Authorized for Kids Under 5 Years
This age group is now eligible to receive the booster dose at least 2 months after they complete primary vaccination with 3 doses of the monovalent vaccine.
Lying and Vaccine Disinformation Among Parents
Approximately 25% of parents lie about their child’s COVID-19 vaccine status or don’t quarantine their children, survey findings show.
M-M-R II, Varivax, ProQuad Vaccines Approved for Intramuscular Administration
M-M-R II, Varivax, and ProQuad are supplied in single-dose vials as lyophilized vaccine for SC or IM injection after reconstitution.
ACIP: 2023 Adult Immunization Schedule Updates
Several changes have been made to the adult immunization schedule 2023.
ACIP: 2023 Child and Adolescent Immunization Schedule Updates
Several changes have been made to the child and adolescent immunization schedule for 2023.
Safety Signal in Seniors Prompts Investigation of Bivalent COVID-19 Vaccine
The preliminary safety signal was identified by the CDC’s Vaccine Safety Datalink.
Bivalent COVID-19 Vaccines Authorized for Children 6 Months and Older
The bivalent formulations contain the original strain of the SARS-CoV-2 virus and a strain from the BA.4 and BA.5 lineages of the Omicron variant.
Measles Vaccination Rates Dropped During COVID-19 Pandemic to 81% in 2021
The rate of children receiving a first measles-containing vaccine decreased between 2020 and 2021, CDC says.
- Loading...
Loading...
Loading... 
Loading...